Market Value2,618,868,000
Total Holdings71
File Date2022-08-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OSH / Oak Street Health Inc
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
AYLA / Ayala Pharmaceuticals Inc
ZYME / Zymeworks Inc.
TCRR / Tcr2 Therapeutics Inc
BVS / Bioventus Inc.
AKRO / Akero Therapeutics, Inc.
ADCT / ADC Therapeutics SA
SRRK / Scholar Rock Holding Corporation
VERV / Verve Therapeutics, Inc.
STXS / Stereotaxis, Inc.
LIVN / LivaNova PLC
NVRO / Nevro Corp.
HOOK / HOOKIPA Pharma Inc.
TNDM / Tandem Diabetes Care, Inc.
IMTX / Immatics N.V.
CABA / Cabaletta Bio, Inc.
PLRX / Pliant Therapeutics, Inc.
ALXO / ALX Oncology Holdings Inc.
PRVA / Privia Health Group, Inc.
HZNP / Horizon Therapeutics Plc
JAZZ / Jazz Pharmaceuticals plc
TKNO / Alpha Teknova, Inc.
FOLD / Amicus Therapeutics, Inc.
SGEN / Seagen Inc
STVN / Stevanato Group S.p.A.
KRYS / Krystal Biotech, Inc.
ALVR / AlloVir, Inc.
BEAM / Beam Therapeutics Inc.
CLDX / Celldex Therapeutics, Inc.
EPZM / Epizyme Inc
BMRN / BioMarin Pharmaceutical Inc.
MDVL / MedAvail Holdings, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
RGNX / REGENXBIO Inc.
ICUI / ICU Medical, Inc.
PRTA / Prothena Corporation plc
/ ONCOLOGY INSTITUTE INC/THE
TRDA / Entrada Therapeutics, Inc.
UNH / UnitedHealth Group Incorporated
ONEM / 1life Healthcare Inc
XENE / Xenon Pharmaceuticals Inc.
SKIN / The Beauty Health Company
SONX / Sonendo, Inc.
CTSO / Cytosorbents Corporation
XERS / Xeris Biopharma Holdings, Inc.
LSAQ / LifeSci Acquisition II Corp
ISEE / IVERIC bio Inc
ELV / Elevance Health, Inc.
CNC / Centene Corporation
NLTX / Neoleukin Therapeutics, Inc.
SLGC / Standard BioTools Inc.
IMGN / ImmunoGen, Inc.
ABSI / Absci Corporation
STOK / Stoke Therapeutics, Inc.
AUGX / Augmedix, Inc.
BCEL / Atreca, Inc.
IVVD / Invivyd, Inc.
NVTA / Invitae Corporation
ANNX / Annexon, Inc.
RPTX / Repare Therapeutics Inc.
RAPT / RAPT Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
REPL / Replimune Group, Inc.
STTK / Shattuck Labs, Inc.
GRTSQ / Gritstone bio, Inc.
ATRA / Atara Biotherapeutics, Inc.
KYMR / Kymera Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
NRIX / Nurix Therapeutics, Inc.
LVTX / LAVA Therapeutics N.V.
ALLK / Allakos Inc.